Greenwich LifeSciences Aktie
WKN DE: A2P794 / ISIN: US3968791083
10.09.2025 12:30:12
|
Greenwich LifeSciences Gets Fast Track Designation For GLSI-100
(RTTNews) - Greenwich LifeSciences, Inc. (GLSI) Wednesday said that it has received Fast Track Designation for GLSI-100 in the HLA-A*02 population of breast cancer patients.
Key benefits of Fast Track Designation include more frequent meetings with the FDA, eligibility for Accelerated Approval and Priority Review, if relevant criteria are met, and Rolling Review.
A Phase 3 study dubbed FLAMINGO-01 evaluating GLSI-100 , an immunotherapy to prevent breast cancer recurrences, is ongoing.

Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu Greenwich LifeSciences Inc Registered Shsmehr Nachrichten
Keine Nachrichten verfügbar. |
Analysen zu Greenwich LifeSciences Inc Registered Shsmehr Analysen
Aktien in diesem Artikel
Greenwich LifeSciences Inc Registered Shs | 10,16 | -2,31% |
|